{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T02:03:40Z","timestamp":1760061820532,"version":"3.44.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.ejso.2019.06.021","type":"journal-article","created":{"date-parts":[[2019,6,13]],"date-time":"2019-06-13T12:42:36Z","timestamp":1560429756000},"page":"2103-2108","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Clinico-pathological outcomes after total parietal peritonectomy, cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in advanced serous papillary peritoneal carcinoma submitted to neoadjuvant systemic chemotherapy- largest single institute experience"],"prefix":"10.1016","volume":"45","author":[{"given":"Marcello","family":"Deraco","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Snita","family":"Sinukumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosa Ang\u00e9lica","family":"Salcedo-Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vinayakumar J.","family":"Rajendra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dario","family":"Baratti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcello","family":"Guaglio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eran","family":"Nizri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeki","family":"Kusamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejso.2019.06.021_bib1","article-title":"Long-term survival of high-grade primary peritoneal papillary serous adenocarcinoma: a case report and literature review","volume":"15","author":"Yuan","year":"2017","journal-title":"World J Surg Oncol [Internet]"},{"issue":"1","key":"10.1016\/j.ejso.2019.06.021_bib2","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0002-9378(59)90287-X","article-title":"Mesothelioma of the pelvic peritoneum resembling papillary cystadenocarcinoma of the ovary; case report","volume":"77","author":"Swerdlow","year":"1959","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.ejso.2019.06.021_bib3","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1006\/gyno.1998.5090","article-title":"Prognostic factors in extraovarian primary peritoneal carcinoma","volume":"71","author":"Eltabbakh","year":"1998","journal-title":"Gynecol Oncol"},{"issue":"7","key":"10.1016\/j.ejso.2019.06.021_bib4","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1002\/ijc.23287","article-title":"Serous ovarian, fallopian tube and primary peritoneal cancers: a comparative epidemiological analysis","volume":"122","author":"Jordan","year":"2008","journal-title":"Int J Cancer"},{"issue":"3","key":"10.1016\/j.ejso.2019.06.021_bib5","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1006\/gyno.1993.1223","article-title":"Extraovarian peritoneal serous papillary carcinoma: a case-control retrospective comparison to papillary adenocarcinoma of the ovary","volume":"50","author":"Bloss","year":"1993","journal-title":"Gynecol Oncol"},{"issue":"24","key":"10.1016\/j.ejso.2019.06.021_bib6","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1056\/NEJMra041842","article-title":"Cancer of the ovary","volume":"351","author":"Cannistra","year":"2004","journal-title":"N\u00a0Engl J Med"},{"issue":"suppl_5","key":"10.1016\/j.ejso.2019.06.021_bib7","doi-asserted-by":"crossref","first-page":"v23","DOI":"10.1093\/annonc\/mdq244","article-title":"Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"21","author":"Colombo","year":"2010","journal-title":"Ann Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2019.06.021_bib8","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/00000658-199501000-00004","article-title":"Peritonectomy procedures","volume":"221","author":"Sugarbaker","year":"1995","journal-title":"Ann Surg"},{"issue":"9","key":"10.1016\/j.ejso.2019.06.021_bib9","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1245\/s10434-008-9966-2","article-title":"8-year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer","volume":"15","author":"Verwaal","year":"2008","journal-title":"Ann Surg Oncol"},{"issue":"20","key":"10.1016\/j.ejso.2019.06.021_bib10","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1200\/JCO.2011.39.7166","article-title":"Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy","volume":"30","author":"Chua","year":"2012","journal-title":"J\u00a0Clin Oncol Off J Am Soc Clin Oncol"},{"key":"10.1016\/j.ejso.2019.06.021_bib11","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.critrevonc.2016.01.017","article-title":"Progress in treatments for colorectal cancer peritoneal metastases during the years 2010-2015. A systematic review","volume":"100","author":"Baratti","year":"2016","journal-title":"Crit Rev Oncol Hematol"},{"issue":"5","key":"10.1016\/j.ejso.2019.06.021_bib12","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1245\/s10434-014-3978-x","article-title":"Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: a systematic review and meta-analysis","volume":"22","author":"Helm","year":"2015","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2019.06.021_bib13","doi-asserted-by":"crossref","first-page":"31","DOI":"10.4251\/wjgo.v2.i1.31","article-title":"Selection of patients and staging of peritoneal surface malignancies","volume":"2","author":"Eddy Cotte","year":"2010","journal-title":"World J Gastrointest Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2019.06.021_bib14","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.ygyno.2011.05.004","article-title":"Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy as upfront therapy for advanced epithelial ovarian cancer: multi-institutional phase-II trial","volume":"122","author":"Deraco","year":"2011","journal-title":"Gynecol Oncol"},{"issue":"25","key":"10.1016\/j.ejso.2019.06.021_bib15","doi-asserted-by":"crossref","first-page":"3793","DOI":"10.2174\/138161212802002616","article-title":"Survival benefit of adding Hyperthermic IntraPEritoneal Chemotherapy (HIPEC) at the different time-points of treatment of ovarian cancer: review of evidence","volume":"18","author":"Mulier","year":"2012","journal-title":"Curr Pharm Des"},{"issue":"4","key":"10.1016\/j.ejso.2019.06.021_bib16","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1245\/s10434-016-5686-1","article-title":"Cytoreduction (peritonectomy procedures) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) in advanced ovarian cancer: retrospective Italian multicenter observational study of 511 cases","volume":"24","author":"Di","year":"2017","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"10.1016\/j.ejso.2019.06.021_bib17","first-page":"256","article-title":"Hyperthermic intraperitoneal chemotherapy added to the treatment of ovarian cancer. A review of achieved results and complications","volume":"31","author":"Dovern","year":"2010","journal-title":"Eur J Gynaecol Oncol"},{"issue":"15_suppl","key":"10.1016\/j.ejso.2019.06.021_bib18","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2017.35.15_suppl.5519","article-title":"A\u00a0phase 3 trial of hyperthermic intraperitoneal chemotherapy (HIPEC) for ovarian cancer","volume":"35","author":"Van Driel","year":"2017","journal-title":"J\u00a0Clin Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2019.06.021_bib19","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.critrevonc.2009.10.003","article-title":"Serous papillary peritoneal carcinoma: unknown primary tumour, ovarian cancer counterpart or a distinct entity? A systematic review","volume":"75","author":"Pentheroudakis","year":"2010","journal-title":"Crit Rev Oncol Hematol"},{"issue":"1","key":"10.1016\/j.ejso.2019.06.021_bib20","first-page":"132","article-title":"Incidence of ovarian, peritoneal, and fallopian tube carcinomas in the United States, 1995-2004","volume":"18","author":"Goodman","year":"2009","journal-title":"Cancer Epidemiol Biomark Prev Publ Am Assoc Cancer Res Cosponsored Am Soc Prev Oncol"},{"issue":"4","key":"10.1016\/j.ejso.2019.06.021_bib21","first-page":"407","article-title":"Clinical characteristics of primary peritoneal carcinoma patients: a single-institution experience involving 8 patients","volume":"78","author":"Hattori","year":"2016","journal-title":"Nagoya J Med Sci"},{"issue":"3","key":"10.1016\/j.ejso.2019.06.021_bib22","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.ygyno.2015.01.534","article-title":"Serous ovarian, fallopian tube and primary peritoneal cancers: a common disease or separate entities - a systematic review","volume":"136","author":"S\u00f8rensen","year":"2015","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejso.2019.06.021_bib23","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1309\/P51M-B66M-JFKW-ER5A","article-title":"Distinct allelic loss patterns in papillary serous carcinoma of the peritoneum","volume":"114","author":"Huang","year":"2000","journal-title":"Am J Clin Pathol"},{"issue":"2","key":"10.1016\/j.ejso.2019.06.021_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2007.07.003","article-title":"Platinum resistance and impaired survival in patients with advanced primary peritoneal carcinoma: matched-case comparison with patients with epithelial ovarian carcinoma","volume":"198","author":"Eisenhauer","year":"2008","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.ejso.2019.06.021_bib25","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1097\/00004347-200110000-00005","article-title":"Immunohistochemical comparison of primary peritoneal and primary ovarian serous papillary carcinoma","volume":"20","author":"Halperin","year":"2001","journal-title":"Int J Gynecol Pathol Off J Int Soc Gynecol Pathol"},{"issue":"2","key":"10.1016\/j.ejso.2019.06.021_bib26","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ygyno.2013.12.002","article-title":"Neoadjuvant chemotherapy with six cycles of carboplatin and paclitaxel in advanced ovarian cancer patients unsuitable for primary surgery: safety and effectiveness","volume":"132","author":"Da Costa Miranda","year":"2014","journal-title":"Gynecol Oncol"},{"issue":"9","key":"10.1016\/j.ejso.2019.06.021_bib27","first-page":"976","article-title":"Prognosis of stage III or IV primary peritoneal serous papillary carcinoma","volume":"30","author":"Dubernard","year":"2004","journal-title":"Eur J Surg Oncol J Eur Soc Surg Oncol Br Assoc Surg Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2019.06.021_bib28","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1159\/000338402","article-title":"Paclitaxel plus carboplatin chemotherapy for primary peritoneal carcinoma: a study of 22 cases and comparison with stage III\u2013IV ovarian serous carcinoma","volume":"5","author":"Kawaguchi","year":"2012","journal-title":"Case Rep Oncol"},{"issue":"8","key":"10.1016\/j.ejso.2019.06.021_bib29","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1097\/IGC.0b013e31826a3559","article-title":"Maximal cytoreduction in patients with FIGO stage IIIC to stage IV ovarian, fallopian, and peritoneal cancer in day-to-day practice: a Retrospective French Multicentric Study","volume":"22","author":"Luyckx","year":"2012","journal-title":"Int J Gynecol Cancer Off J Int Gynecol Cancer Soc"},{"issue":"9","key":"10.1016\/j.ejso.2019.06.021_bib30","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1056\/NEJMoa1808424","article-title":"A\u00a0randomized trial of lymphadenectomy in patients with advanced ovarian neoplasms","volume":"380","author":"Harter","year":"2019","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.ejso.2019.06.021_bib31","first-page":"1387","article-title":"The involvement of retroperitoneal lymph nodes in primary serous-papillary peritoneal carcinoma. a systematic review of the literature","volume":"31","author":"Steinhagen","year":"2011","journal-title":"Anticancer Res"},{"issue":"3","key":"10.1016\/j.ejso.2019.06.021_bib32","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/(SICI)1096-9098(199807)68:3<173::AID-JSO8>3.0.CO;2-2","article-title":"Peritoneal papillary serous carcinoma: study of 15 cases and comparison with stage III-IV ovarian papillary serous carcinoma","volume":"68","author":"Piura","year":"1998","journal-title":"J\u00a0Surg Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2019.06.021_bib33","doi-asserted-by":"crossref","first-page":"65","DOI":"10.4143\/crt.2007.39.2.65","article-title":"Clinical characteristics of primary peritoneal carcinoma","volume":"39","author":"Roh","year":"2007","journal-title":"Cancer Res Treat Off J Korean Cancer Assoc"},{"issue":"1","key":"10.1016\/j.ejso.2019.06.021_bib34","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.tjog.2012.10.003","article-title":"Prognosis for advanced-stage primary peritoneal serous papillary carcinoma and serous ovarian cancer in Taiwan","volume":"52","author":"Chao","year":"2013","journal-title":"Taiwan J Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.ejso.2019.06.021_bib35","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.ygyno.2014.08.020","article-title":"Demographic clinical and prognostic characteristics of primary ovarian, peritoneal and tubal adenocarcinomas of serous histology--a prospective comparative study","volume":"135","author":"Schnack","year":"2014","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.ejso.2019.06.021_bib36","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1007\/s12253-011-9375-x","article-title":"Primary peritoneal serous papillary carcinoma: a clinical and pathological study","volume":"17","author":"Liu","year":"2011","journal-title":"Pathol Oncol Res POR"},{"issue":"7","key":"10.1016\/j.ejso.2019.06.021_bib37","first-page":"742","article-title":"Primary peritoneal serous carcinoma treated by cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy. A multi-institutional study of 36 patients","volume":"39","author":"Bakrin","year":"2013","journal-title":"Eur J Surg Oncol J Eur Soc Surg Oncol Br Assoc Surg Oncol"},{"issue":"6","key":"10.1016\/j.ejso.2019.06.021_bib38","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1097\/SLA.0b013e3181a45d86","article-title":"Should the treatment of peritoneal carcinomatosis by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy still be regarded as a highly morbid procedure?: a systematic review of morbidity and mortality","volume":"249","author":"Chua","year":"2009","journal-title":"Ann Surg"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798319305153?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798319305153?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T16:05:07Z","timestamp":1755273907000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798319305153"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":38,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["S0748798319305153"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2019.06.021","relation":{},"ISSN":["0748-7983"],"issn-type":[{"type":"print","value":"0748-7983"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinico-pathological outcomes after total parietal peritonectomy, cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in advanced serous papillary peritoneal carcinoma submitted to neoadjuvant systemic chemotherapy- largest single institute experience","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2019.06.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}